ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -89.2% | 11,315 | -91.6% | 0.02% | -86.0% |
| Q4 2017 | $390,000 | -25.7% | 135,445 | +15.8% | 0.18% | -28.8% |
| Q3 2017 | $525,000 | -1.9% | 116,945 | +0.3% | 0.25% | -8.1% |
| Q2 2017 | $535,000 | +400.0% | 116,630 | +358.6% | 0.27% | +369.0% |
| Q1 2017 | $107,000 | +15.1% | 25,430 | +13.4% | 0.06% | +16.0% |
| Q4 2016 | $93,000 | -4.1% | 22,430 | +88.0% | 0.05% | -3.8% |
| Q3 2016 | $97,000 | – | 11,930 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |